Target intelligence / Profile preview

ADP-ribosylation factor-like protein 3 (ARL3)

Target
ARL3
Molecular classification
Small GTPase, ARF family, Regulatory protein
01

Overview

ADP-ribosylation factor-like protein 3 (ARL3) is a member of the ARF-like family of small GTPases, functioning as a regulatory switch that cycles between inactive GDP-bound and active GTP-bound states[2][3][1]. ARL3 is predominantly involved in the regulation of ciliary trafficking of lipid-modified proteins and is essential for cilium function, photoreceptor development, and maintenance[2][1][4]. It localizes to the centrosome, primary cilium, Golgi apparatus, mitochondria, and endosomes, and can influence processes such as cell division and autophagy regulation[2][3][4]. ARL3 is activated by the guanine exchange factor ARL13B, with cofactors such as BART and ARL2BP facilitating full activation and proper function[1][2]. Dysregulation or mutations in ARL3 cause a spectrum of ciliopathies, including Joubert syndrome, retinal dystrophies (such as cone-rod dystrophy and retinitis pigmentosa), and other multisystem disorders due to defects in ciliary trafficking and photoreceptor degeneration[2]. No direct pharmacological modulators or clinical drugs acting on ARL3 are currently known.

Other names
ARF like GTPase 3ARFL3JBTS35RP83ARF-like 3ADP ribosylation factor like GTPase 3
02

Biological functions

Ciliary traffickingSignal transductionRegulation of autophagyMicrotubule bindingCell divisionLipid-modified protein transport
03

Disease associations

CiliopathiesRetinal degenerationCone-rod dystrophyJoubert syndromeOther inherited retinal diseases
04

Safety considerations

Therapeutic targeting could potentially disrupt normal ciliary function and photoreceptor maintenance, leading to severe multisystem phenotypes and retinal degeneration[2].

Beyond the preview

Go deeper on ADP-ribosylation factor-like protein 3 (ARL3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ADP-ribosylation factor-like protein 3 (ARL3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call